**Core Concept**
The recumbent stage of Hepatitis B is a critical phase in the natural history of the disease, characterized by a period of acute infection and liver inflammation. During this stage, the virus replicates and the immune system responds to the infection, leading to the production of antibodies and immune complexes. The liver parenchyma is damaged, and there is an influx of inflammatory cells.

**Why the Correct Answer is Right**
The correct answer is related to the immune complex-mediated injury to the liver. In the recumbent stage, the hepatitis B virus (HBV) antigen-antibody complexes form and deposit in the liver sinusoids, leading to activation of the complement system and an inflammatory response. This results in liver damage, characterized by hepatocellular necrosis and inflammation. The liver's response to the infection is also marked by the production of cytokines and chemokines, which further exacerbate the inflammatory process.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the liver's response to HBV infection. While there is some degree of liver cell damage, the primary mechanism of injury is not due to direct viral cytopathic effect.
**Option B:** This option is incorrect because it does not accurately describe the pathogenesis of the recumbent stage of Hepatitis B. The liver damage is not primarily due to the direct effect of HBV on liver cells, but rather due to immune complex-mediated injury.
**Option C:** This option is incorrect because it does not accurately describe the clinical manifestations of the recumbent stage of Hepatitis B. While patients may experience some degree of liver dysfunction, the primary clinical feature is not jaundice.

**Clinical Pearl / High-Yield Fact**
The recumbent stage of Hepatitis B is a critical phase in the natural history of the disease, and understanding the pathogenesis of liver damage is essential for the development of effective therapeutic strategies. The formation of HBV antigen-antibody complexes is a key event in the pathogenesis of liver injury, and targeting this process may provide a novel approach to the treatment of Hepatitis B.

**Correct Answer: B. Immune complex-mediated injury**